Pretzel Therapeutics
Biotechnology ResearchView the employees at
Pretzel Therapeutics-
Simon Giroux VP, Chemistry at Pretzel Therapeutics
-
Cambridge, Massachusetts, United States
-
Rising Star
David Ehmann VP at Pretzel Therapeutics-
Lexington, Massachusetts, United States
-
Rising Star
Mattias Stamgren Associate Scientist at Pretzel Therapeutics-
Rising Star
-
Top 10%
Johanna Lönnermark Associate Scientist at Pretzel Therapeutics-
Greater Gothenburg Metropolitan Area
-
Rising Star
Overview
Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology. Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders. At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.
-